Skip to main content
main-content
Top

12-11-2019 | Ankylosing spondylitis | Video | Article

ACR/ARP 2019

Researcher comment: The SELECT-AXIS 1 trial

share
SHARE
print
PRINT
insite
SEARCH

Désirée van der Heijde discusses the results of SELECT-AXIS 1, a phase II/III trial demonstrating that upadacitinib may be a promising treatment option for ankylosing spondylitis (2:27).

Transcript

Back to the ACR/ARP 2019 conference hub

share
SHARE
print
PRINT

New additions to the Adis Journal Club

A monthly selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

EULAR 2022 Congress coverage

Access the latest news and expert insight from the EULAR 2022 Congress.